ClinicalTrials.gov
public full text
Public Domain
Acute Myocardial Infarction and Unstable Angina Patients With PCSK9 Inhibitor Usage Study
Acute coronary syndrome (ACS) is a lethal disease, reduced low-density lipoprotein (LDL) cholesterol due to inhibition of proprotein convertase subtilisin/kexin 9 (PCSK9) reduces cardiovascular events and improve cardiovascular prognosis. we assuming that PCSK9 inhibitor could bring metabolic change in serum, in order to investigate the metabolic modification, we conduct this clinical trial.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Angiotensin Converting Enzyme Inhibitors and Periprocedural Myocardial Infarction#1057068
- CArdioMetabolism and Atherosclerotic PlaqUe progreSsion#1140824
- PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis#850065
- Evaluation of Lipoproteins#802700
- Intensive Lipid Lowering Treatment in Non-ST-elevation Acute Coronary Syndrome (NSTE-ACS) Patients#835283
Record · ID 908356
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive